Table 1.

Estimated Mycoplasma genitalium prevalence, including key characteristics and co-infections

CHARACTERISTICNPREVALENCE, % (95% CI)
All participants (n = 1193)
Positive test results for Mycoplasma genitalium504.2 (3.2 to 5.5)
Positive test results for Chlamydia trachomatis625.2 (4.0 to 6.6)
Positive test results for Neisseria gonorrhoeae524.4 (3.3 to 5.7)
Men/Trans clinic (n = 884)
Indeterminate20.2 (0.0 to 0.8)
Positive test results for M genitalium404.5 (3.3 to 6.1)
  • Symptomatic2050.0 (33.8 to 66.2)
  • Macrolide resistance2562.4 (45.8 to 77.3)
Co-infections
  • M genitalium, C trachomatis, and N gonorrhoeae10.1 (0.0 to 0.6)
  • M genitalium and N gonorrhoeae40.5 (0.1 to 1.2)
  • C trachomatis and N gonorrhoeae111.2 (0.6 to 2.2)
Women/Trans clinic (n = 309)
Indeterminate31.0 (0.2 to 2.8)
Positive test results for M genitalium103.2 (1.6 to 5.9)
  • Symptomatic440.0 (12.2 to 73.8)
  • Macrolide resistance440.0 (12.2 to 73.8)
Co-infections
  • M genitalium and C trachomatis10.3 (0.0 to 1.8)